This financing signals that translating advanced AI insights into clinical practice requires building complex, dedicated physical infrastructure across both US and Canadian sites.
The challenge of drug discovery has historically been defined by attrition. A molecule can show immense promise, only to fall through the rigorous gauntlet of preclinical and early clinical testing for reasons...
The core strength of Biossil Inc. lies not in molecular engineering, but in its sophisticated application of natural language processing (NLP) to solve a systemic problem: the massive loss of therapeutic value...